Keyword: Eli Lilly

Markets & Companies

Pharma Players Mostly Lift 2015 Guidance

07.10.2015 - After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...

News

Sanofi and Lilly Settle Lantus Patent Row

29.09.2015 - France’s Sanofi and US drugmaker Eli Lilly have resolved their patent dispute over insulin drugs. The settlement announced this week ends a US lawsuit brought by the French...

News

Lilly Wins Court Ruling on Alimta Patent

27.08.2015 - A court in Indiana, USA, has ruled in Eli Lilly’s favor in a long-running patent battle with Teva Pharmaceutical Industries relating to infringement of the vitamin regimen for its...

News

Eli Lilly Raises Hope of Alzheimer’s Breakthrough

29.07.2015 - A new experimental Alzheimer’s drug, solanezumab, developed by Eli Lilly has raised hopes for a breakthrough in the treatment of the disease. The progress was reported at the...

News

AstraZeneca Sells Gastro Treatment to Swiss Group Tillotts

13.07.2015 - In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...

News

Catalent Invests in Automated Packaging to Support Lilly

05.09.2014 - Catalent Pharma Solutions is installing new automated prefilled syringe clinical packaging lines at its Clinical Supply Center of Excellence in Philadelphia, Pennsylvania, USA, to...

Markets & Companies

M&A in Chemicals & Pharmaceuticals

02.09.2014 - The first half suggests that 2014 will be a record year for M&A in pharmaceuticals, with the size of deals having increased substantially over prior years. In 2011, the deal volume...

News

Roche Alzheimer's Drug Fails Main Goals in Mid-stage Study

17.07.2014 - Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...